Professor Nick Gottardo, a leading paediatric oncologist, has been nominated for the 2026 Western Australian of the Year award in recognition of his revolutionary contributions to childhood cancer treatment. His work has dramatically improved survival rates and quality of life for young patients across the state and beyond.
Groundbreaking Research in Paediatric Oncology
Professor Gottardo’s research focuses on developing less toxic and more effective therapies for children with cancer. His team at the Telethon Kids Institute and Perth Children’s Hospital has pioneered new treatment protocols that reduce long-term side effects while increasing cure rates. One of his key achievements includes the development of targeted therapies for high-risk brain tumours, which previously had very poor outcomes.
Impact on Young Patients and Families
The new treatments have not only improved survival but also minimised the harsh side effects often associated with traditional chemotherapy and radiation. Families have reported better quality of life during and after treatment, with children able to return to school and normal activities sooner. Professor Gottardo’s patient-centred approach has been widely praised by colleagues and families alike.
Recognition and Future Directions
The nomination for Western Australian of the Year highlights the significant impact of his work. Professor Gottardo expressed gratitude for the recognition but emphasised that the real heroes are the children and families who bravely face cancer. He continues to lead clinical trials and research aimed at further improving outcomes, with a focus on personalised medicine and immunotherapy.
The Western Australian of the Year awards celebrate individuals who have made outstanding contributions to the state. The winner will be announced at a ceremony in Perth later this year. Professor Gottardo’s nomination underscores the importance of medical research and the dedication of healthcare professionals in advancing child health.
